dmsa- dimercaptosuccinic acid injection, powder, lyophilized, for solution
ge healthcare - dimercaptocuccinic acid (unii: 4s9ju7xf01) (dimercaptocuccinic acid - unii:4s9ju7xf01) - injection, powder, lyophilized, for solution - 1 mg - dmsa is to be used as an aid in the scintigraphic evaluation of renal parenchymal disorders. none known.
renocis radiofarmaceutisk præparationssæt
technescan dmsa radiofarmaceutisk præparationssæt
shirtan liquid fungicide
nufarm australia limited - mercury as methoxy ethyl mercury chloride; methanol - liquid concentrate - mercury as methoxy ethyl mercury chloride mercury active 120.0 g/l; methanol solvent other 179.0 g/l - fungicide - sugar cane setts | sugarcane setts - pineapple disease | ceratocystis paradoxa
trisenox 10mg10ml concentrate for solution for infusion ampoules
teva uk ltd - arsenic trioxide - solution for infusion - 1mg/1ml
trisenox 2 mgml
teva pharmaceutical industries ltd, israel - arsenic trioxide - concentrate for solution for injection - arsenic trioxide 2 mg / 1 ml - arsenic trioxide - trisenox is indicated for induction of remission, and consolidation in adult patients with:• newly diagnosed low-to-intermediate risk acute promyelocytic leukaemia (apl) (white blood cell count, ≤ 10 x 103/µl) in combination with all trans retinoic acid (atra)• relapsed/refractory acute promyelocytic leukaemia (apl)(previous treatment should have included a retinoid and chemotherapy) characterised by the presence of the t(15;17) translocation and/or the presence of the pro-myelocytic leukaemia/retinoic-acid-receptor-alpha (pml/rar-alpha) gene.the response rate of other acute myelogenous leukaemia subtypes to arsenic trioxide has not been examined.
renocis 1 mg 5 vials pols
arsentrioxid stada 1 mg/ml konzentrat zur herstellung einer infusionslösung